<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04022395</url>
  </required_header>
  <id_info>
    <org_study_id>519REG2016</org_study_id>
    <nct_id>NCT04022395</nct_id>
  </id_info>
  <brief_title>Stress CMR in Pediatric Patients With Suspected Coronary Artery Disease</brief_title>
  <official_title>Concordance Between Stress CMR and Coronary Angiography in Pediatric Patients With Suspected Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Giannina Gaslini</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Giannina Gaslini</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      stress cMRI with Dobutamine stress agent (stress cMRI), represent the combination of two&#xD;
      orders of exams routinely performed (cMRI and stress diagnostic series of exams) without&#xD;
      additional risk for the patient, but with the advantage of non-invasiveness and lack of&#xD;
      radiation, and less laborious for the participants&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical revascularization or angioplasty are therapeutic options for coronary lesions even&#xD;
      in infants and children. Pharmacological stress induced cMRI could provide crucial&#xD;
      information such as coronary arteries origin and proximal pathway, wall motion abnormalities,&#xD;
      myocardial perfusion and viability, enabling accurate monitoring of symptomatic and&#xD;
      non-pediatric patients. Investigators would build a prospective series of stress cMRI exams&#xD;
      in pediatric symptomatic and non-patients, with suspected or previously diagnosed coronary&#xD;
      artery disease. Investigators would put the results in comparison with ECG, Exercise test,&#xD;
      stress Cardiac Ultrasound and Angiography. At the end of the study, if supported by results,&#xD;
      the aim is to replace the current diagnostic procedure (ECG, Exercise test, stress Cardiac&#xD;
      Ultrasound and Angiography) which need long hospitalization, expose the patient to radiation&#xD;
      dose, is uncomfortable for the patient, and is characterized by a non-negligible risk due to&#xD;
      invasive procedure, with a single exam (stress cMRI) which is dose-free, minimal risk&#xD;
      related, without hospitalization, and less expensive for National Care System.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 18, 2018</start_date>
  <completion_date type="Actual">March 30, 2021</completion_date>
  <primary_completion_date type="Actual">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Multiparameters diagnostic concordance</measure>
    <time_frame>24 month</time_frame>
    <description>â€¢ Agreement of results between stress cMRI and the current practice constituted by Exercise test, Stress Cardiac Ultrasound and Invasive Angiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy of stress cMRI</measure>
    <time_frame>24 month</time_frame>
    <description>Predictive value of stress cMRI to determine the incidence of post-surgical complication of switch repair, and other pathological conditions affecting coronary arteries in natural history, in comparison with tradition test. This will be measured the number coronary segments affected, and consequences on wall motion abnormalities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Treatment-Emergent Adverse Events</measure>
    <time_frame>24 month</time_frame>
    <description>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>stress cardiac MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To optimize the scan protocol and the sequence parameters&#xD;
To investigate the clinical compliance of stress induced cardiac MRI in pediatric patients&#xD;
To test the ability of stress cMRI to visualize coronary arteries morphological irregularities, the corresponding wall motion abnormalities and perfusion - viability features</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>stress cardiac MRI</intervention_name>
    <description>pharmacological stress testing has evolved as an alternative to physical exercise for the detection of inducible myocardial ischemia</description>
    <arm_group_label>stress cardiac MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between 8 and 18 years-old patients symptomatic and non, with suspected or previously&#xD;
             diagnosed coronary arteries disease&#xD;
&#xD;
               -  Coronary artery re-implantation after arterial switch&#xD;
&#xD;
               -  ALCAPA Syndrome, and other anomalies of origin or pathway&#xD;
&#xD;
               -  replacement of aortica valve with pulmonary autograft (Ross procedure)&#xD;
&#xD;
               -  Kawasaki disease&#xD;
&#xD;
               -  primary dilatative cardiomyopathy&#xD;
&#xD;
               -  coronary atresia&#xD;
&#xD;
               -  familiar Hypercholesterolemia&#xD;
&#xD;
               -  bicuspid aortic valve&#xD;
&#xD;
               -  chest pain&#xD;
&#xD;
               -  exertional dyspnea of suspected coronary artery nature&#xD;
&#xD;
               -  coronary artery fistula&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  General contraindication to MRI (non MRI compatible device: vascular clips, foreign&#xD;
             bodies, coronary and peripheral artery stents, aortic stent grafts, prosthetic heart&#xD;
             valves and annuloplasty rings, cardiac occluder devices, vena cava filters and&#xD;
             embolisation coils, haemodynamic monitoring and temporary pacing devices, haemodynamic&#xD;
             support devices, permanent cardiac pacemakers and implantable&#xD;
             cardioverter-defibrillators, retained transvenous pacemaker and defibrillator leads,&#xD;
             cochlear implants, claustrophobia, pregnancy and postpartum),&#xD;
&#xD;
               -  contraindication to contrast agent (renal insufficiency, hypersensitivity to the&#xD;
                  Dotarem active substance or to any of the excipients:)&#xD;
&#xD;
               -  contraindication to stress agent (hypersensitivity to Dobutamine active substance&#xD;
                  or to any of the excipients)&#xD;
&#xD;
               -  severe arterial hypertension (&gt;/= 220/120 mmHg)&#xD;
&#xD;
               -  unstable angina pectoris&#xD;
&#xD;
               -  significant aortic stenosis&#xD;
&#xD;
               -  complex cardiac arrhythmias including uncontrolled atrial fibrillation&#xD;
&#xD;
               -  hypertrophic obstructive cardiomyopathy&#xD;
&#xD;
               -  myocarditis, endocerditis&#xD;
&#xD;
               -  pericarditis&#xD;
&#xD;
               -  uncontrolled congestive heart failure&#xD;
&#xD;
               -  previous manifestations of hypersensitivity to dobutamine&#xD;
&#xD;
               -  refuse to join the protocol and relative off-label procedures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istituto Giannina Gaslini</name>
      <address>
        <city>Genova</city>
        <zip>16100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 15, 2019</study_first_submitted>
  <study_first_submitted_qc>July 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2019</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Giannina Gaslini</investigator_affiliation>
    <investigator_full_name>Nicola Stagnaro</investigator_full_name>
    <investigator_title>MD, Principal Investigator, Radiology Dept, Cardiovascular MRI Team</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 9, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/95/NCT04022395/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

